Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-19

Clinical Trial Update: Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating subcutaneously injected prandial insulins versus insulin lispro alone in adults with Type 1 diabetes; completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • insulin lispro (insulin lispro)
  • prandial insulins (subcutaneously injected)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2014-08-19